Peg-Interferon Plus Ribavirin with or without Boceprevir or Telaprevir for HCV Genotype 1: A Meta-Analysis on the Role of Response Predictors
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peg-Interferon Plus Ribavirin with or without Boceprevir or Telaprevir for HCV Genotype 1: A Meta-Analysis on the Role of Response Predictors
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 4, Pages e94542
Publisher
Public Library of Science (PLoS)
Online
2014-04-12
DOI
10.1371/journal.pone.0094542
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Update on the Management of Chronic Hepatitis C: Consensus Guidelines from the Canadian Association for the Study of the Liver
- (2016) Robert P Myers et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Ledipasvir: a novel synthetic antiviral for the treatment of HCV infection
- (2014) Ivan Gentile et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Comparative Effectiveness of Antiviral Treatment for Hepatitis C Virus Infection in Adults: A Systematic Review
- (2013) Roger Chou et al. ANNALS OF INTERNAL MEDICINE
- Telaprevir Versus Boceprevir in Chronic Hepatitis C: A Meta-Analysis of Data From Phase II and III Trials
- (2013) Mugdha Sitole et al. CLINICAL THERAPEUTICS
- Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure
- (2013) Stanislas Pol et al. JOURNAL OF HEPATOLOGY
- UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients
- (2012) P. Ramachandran et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Update on the Management and Treatment of Hepatitis C Virus Infection: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office
- (2012) Helen S Yee et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis
- (2012) Nicola Coppola et al. BMC INFECTIOUS DISEASES
- Boceprevir With Peginterferon Alfa-2a–Ribavirin Is Effective for Previously Treated Chronic Hepatitis C Genotype 1 Infection
- (2012) Steven L. Flamm et al. Clinical Gastroenterology and Hepatology
- The Relative Efficacy of Boceprevir and Telaprevir in the Treatment of Hepatitis C Virus Genotype 1
- (2012) Jennifer Kieran et al. CLINICAL INFECTIOUS DISEASES
- Efficacy of telaprevir and boceprevir in treatment-naïve and treatment-experienced genotype 1 chronic hepatitis C patients: an indirect comparison using Bayesian network meta-analysis
- (2012) S. Cure et al. CURRENT MEDICAL RESEARCH AND OPINION
- Directly acting antivirals for the treatment of chronic hepatitis C: Unresolved topics from registration trials
- (2012) Alessio Aghemo et al. DIGESTIVE AND LIVER DISEASE
- Maximizing Opportunities and Avoiding Mistakes in Triple Therapy for Hepatitis C Virus
- (2012) A. Sidney Barritt et al. GASTROENTEROLOGY
- Factors That Predict Response of Patients With Hepatitis C Virus Infection to Boceprevir
- (2012) Fred Poordad et al. GASTROENTEROLOGY
- New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives
- (2012) Christoph Welsch et al. GUT
- Will IL28B polymorphism remain relevant in the era of direct-acting antiviral agents for hepatitis C virus?
- (2012) Alexander J. Thompson et al. HEPATOLOGY
- New therapies for chronic hepatitis C infection: a systematic review of evidence from clinical trials
- (2012) L. Y. Lee et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Antiviral strategies in hepatitis C virus infection
- (2012) Christoph Sarrazin et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of boceprevir plus peginterferon–ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosis
- (2012) Savino Bruno et al. JOURNAL OF HEPATOLOGY
- Does IL28B genotyping still have a role in the era of direct-acting antiviral therapy for chronic hepatitis C infection?
- (2012) J. A. Holmes et al. JOURNAL OF VIRAL HEPATITIS
- A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C
- (2012) I. M. Jacobson et al. JOURNAL OF VIRAL HEPATITIS
- Protease inhibitors for the treatment of chronic hepatitis C genotype-1 infection: the new standard of care
- (2012) Brian L Pearlman LANCET INFECTIOUS DISEASES
- Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver
- (2012) Vincent Leroy et al. LIVER INTERNATIONAL
- Boceprevir and Telaprevir in the Management of Hepatitis C Virus-Infected Patients
- (2011) A. A. Butt et al. CLINICAL INFECTIOUS DISEASES
- An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
- (2011) Marc G. Ghany et al. HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
- (2011) JOURNAL OF HEPATOLOGY
- Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan
- (2011) Hiromitsu Kumada et al. JOURNAL OF HEPATOLOGY
- Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical practice
- (2011) Christophe Hézode LIVER INTERNATIONAL
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now